Rectus Sheath Block in Cardiac Surgery

Last updated: August 6, 2024
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting

Phase

N/A

Condition

Post-surgical Pain

Chronic Pain

Cardiac Disease

Treatment

Rectus sheath block

Clinical Study ID

NCT05833048
STUDY-23-00096
  • Ages 18-85
  • All Genders

Study Summary

This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block.

  1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery?

  2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • In order to be eligible to participate in this study, an individual must meet all ofthe following criteria:

  1. Adults 18-85 years old

  2. Scheduled to undergo cardiac procedures involving chest tubes

  3. Male or female

Exclusion

Exclusion Criteria:

  • An individual who meets any of the following criteria will be excluded fromparticipation in this study:

  1. ASA class V

  2. Urgent or emergent surgery

  3. Contraindications to administration of local anesthesia (e.g. local anestheticallergy)

  4. History of substance abuse or chronic opioid use

  5. Patient refusal or inability to consent

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Rectus sheath block
Phase:
Study Start date:
July 29, 2024
Estimated Completion Date:
August 30, 2025

Connect with a study center

  • Mount Sinai Morningside Hospital Center

    New York, New York 10023
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.